India a critical market for Eurofins Scientific

On July 30, 2014, French-based Eurofins Scientific opened its new facility in Whitefield, Bangalore, as a part of its expansion plans in India to tap various growth opportunities and consolidate its operations


Dr Matthias-Wilbur Weber, group executive vice president, Eurofins Scientific inaugurating the new facility in Bangalore

Bangalore: At the inauguration of Eurofins Scientifics' new Bangalore facility, Dr Matthias-Wilbur Weber, group executive vice president, Eurofins Scientific said, "India is a critical market, which is strategically important for our future growth. India will help us grow at the global level from the current 1.3 billion Euros to 2 billion Euros by 2017.

"This new facility demonstrates our commitment to the Indian market, which is strategically important for our growth in the long term. Eurofins is one of the few international players in the testing business to invest in a wholly-owned facility in India. We will expand our offering to bring more and more of the Eurofins portfolio of services to customers here."

Eurofins has been in India since 2009. The new facility is a mix of laboratories and office space measuring over 48,357 sq ft.

Mr Sanjeev Khatri, MD, Eurofins India expressed, "The pace of growth and diversity of activities meant that all entities could not be accommodated in single rented premises. With most of our businesses starting up and quickly reaching profitability, it became quite clear that India will continue to be an attractive market for Eurofins and we shall continue to grow our presence here."

Founded in 1987, the company operates five businesses overall in India, out of which four of them including genomics, food & feed testing, pharma services, and IT Solutions, are located in the new facility at Hoodi, Whitefield, in Bangalore.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email